Firstly, we explored the RNA-sequence data of 675 commonly used human cancer cell lines from the expression database web tool and identified expression levels of the RBBP6, TP53, BCL-2, and MDM2 oncogenes in different CESC cell lines, including HeLa cells (Figure 3A). This evidence concerns the gene BCL2 and cancer.